Loading...
Share this job

Trainee (Translational Sciences 3R)

Selection procedure reference: EMA/TR/1904 

Deadline for applications: 15 July 2020 23:59 CET 

 

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

 

The 2020 Traineeship programme is now open for applications until 15 July 2020 23:59 CET, with an intake on 1 October 2020.

 

1. About the traineeship programme

The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students, who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.

 

Placement description

We are looking for a trainee to support the Translational Sciences Service.

Specific objectives and projects:

During your traineeship, you will participate and contribute to the 3Rs: Replacement, Reduction, and Refinement of animal studies in medicines innovation.


You will be involved in a systematic review of promising alternative methods available, to define their characteristics, advantages and disadvantages in order to gain insight regarding the potentiality of these methods to gain regulatory acceptance.

This systematic review will result in:

  • an internal report for reference and training purposes
  • training materials for the EU-Network Training Centre
  • a peer reviewed publication
Learning outcomes:

We will help you to:

  • Increase your knowledge in the area of 3Rs
  • Gain knowledge of the Agency’s processes and procedures in the area of Qualification of 3Rs alternative methods as well as Marketing Authorisation of human and veterinary medicinal products
  • Share your academic knowledge and your perspective to contribute to the Agency’s objectives in the area of 3Rs
  • Increase understanding of communication with medicines developers, consumer organisations, and regulatory colleagues in national competent authorities

 

Eligibility criteria

To be eligible for consideration for this placement, you are required to:

  1. enjoy full rights as a citizen of a European Union Member State or Iceland, Lichtenstein and Norway;
  2. possess a university degree in physiology/pharmacology/toxicology (minimum of three years or more) that must have been obtained within the last 12 months (July 2019 -July 2020) or be a university student on an Erasmus + or a similar programme or a PhD student.
  3. a thorough knowledge of English (at least level C1) and good knowledge of other official EU language (at least B2) of the Common European Framework for Languages

For criteria 1 and 2, you will be required to provide proof in the application form and at the interview stage. Failing to present these documents may result in the disqualification from the procedure.

Additional skills

In addition to the eligibility criteria, you will have:

  • Basic knowledge about 3Rs EU policy.
  • General understanding of and/or experience with 3Rs alternative methods (e.g. in silico/QSAR, in vitro microphysiological systems, non-primate alternative in vivo models).
  • Good experience in searching and reviewing literature with ability to summarise and report major findings.
Behavioural Competencies

You will demonstrate the following behavioural competencies:

  • Communication skills
  • Interpersonal skills
  • Working with others
  • Adaptability
  • Research and analytical skills
  • Learning and development
Selection timelines

Deadline for applications

15 July 2020 23:59 CET

Assessments (remote)

From 20 July 2020 to 15 August 2020

Decision expected

By 15 August 2020

 Placement start

1 October 2020

Conditions of traineeship

The traineeship is offered for 10 months (1 October 2020 – 31 July 2021) and takes place at the Agency’s premises in Amsterdam. Traineeships are offered for either full-time or part-time (80% or 50%) combined with university studies.

The Agency pays a monthly stipend of €1,360 for a full-time traineeship (reduced accordingly for 80% or 50%) and a travel contribution upon joining and leaving the Agency.

Each trainee will have a mentor at the Agency who will guide the trainee through the programme.

The conditions of employment are stated in the Executive Decision on rules governing the traineeship programme at the EMA available here.

 

______________________________________________________________________________________________________

Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands

Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

 

© European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.